Newsletter

Remed Unveils BrainStim Product Line at KIMES 2024

BrainStim Product Images | Provided by – Remed

Remed Co., Ltd. (CEO Eun-hyeon Ko) announced that it will participate in the 39th International Hospital and Medical Equipment Fair “KIMES 2024”, which will be held at COEX, Seoul from Thursday, March 14 to Sunday, March 17.

Remed is a company with a leadership position in the field of brain stimulation technology and the medical devices that reflect it. Since we developed the NMS (neuromagnetic stimulation) equipment, used to treat various musculoskeletal pain, in 2003, through proprietary technology, we have expanded our activity in the field of transcranial magnetic stimulation, used to treat brain diseases, through continuous research and successful.development.

Furthermore, the company has developed its own CSMS (Core Muscle Strengthen Magnetic Stimulation) equipment to strengthen muscle strength and, based on this, is conducting an aesthetic business, bringing to the market technologies ranging from primary healthcare to high added value equipment.

At this fair, Remed presents a product line of medical devices for various purposes based on magnetic field technology. Among them, “Brainstim” is an updated version of the current medical device for the treatment of depression “ALTMS” and is characterized by the support of precise diagnostic functions along with navigation. At the same time, it is considered a product that maximizes treatment flexibility through various protocols, client management programs and EMG connection.

The “BrainStim100”, also being launched, is a medical device for the treatment of brain injuries made in the form of a portable helmet. The company explains that it is expected to be a product that will lead to the popularization of brain injury treatment as it supports simple treatment with a more compact design than hospital TMS equipment and is more convenient than traditional hospital treatment.

Product image BrainStim100 | Provided by – Remed

In addition, Remed also offers the piezoelectric focused extracorporeal shock wave therapy device “Salus-FSWT”, the complex treatment equipment “Salus ESWT-Expert” using two types of shock waves, and the HIFU device at 3 channels “V1” Exposure is expected.

A Remed official said: “We are increasing the company’s competitiveness day by day by introducing domestically produced products into the market of extracorporeal shock waves and pain-related magnetic fields, which was previously highly dependent on foreign products, and we are generating results by continuing to expand our sales channels abroad.” He said: “In particular, by successfully developing equipment that maximizes the precision and efficiency of brain treatment, Remed is becoming a company with advanced capabilities in the global market in terms of technology.”

“We want to promote innovation in the medical field with new technologies and products and help provide better treatment options for patients,” he said. “In particular, this year’s KIMES will help the company expand its sales and strengthen its position globally.” “We expect this to be a major turning point for us.”

Meanwhile, KIMES is a trade fair specializing in medical devices and hospital equipment which has grown steadily along with the development of Korean medical industry since its first meeting in 1980. Meanwhile, the domestic medical industry has been engaged in medical information systems , ultrasound scanners, medical imaging equipment, robotic medicine, artificial intelligence, has turned into a technology-intensive high-tech industry such as rehabilitation medicine.

→ Go to the special KIMES 2024 news page

#Remed #exhibit #magnetic #field #medical #devices #treatment #brain #injuries #musculoskeletal #diseases #KIMES #2024.. #Expanding #sales #channels #domestically #produced #technologies #products